Liver: peptides in published research
Sources checked 2026-10-07 · 9 compounds · 11 cited studies
Scope: Liver tissue, bile ducts and liver blood flow. Each entry names the model and the tissue that a published study looked at, with the citation. It describes what was studied, not what was found, and a listing here is not a claim that a compound does anything in that organ.
- BPC-157
- MOTS-c
- Selank
- TB-500 (thymosin beta-4)
- Thymosin alpha-1
- Retatrutide
- Semaglutide
- Survodutide
- Tirzepatide
BPC-157
- Animal Rat bile duct ligation model followed up to 8 weeks; liver, bile duct and portal pressure. Published 2019 · PubMed PMID 30690000 ↗
- Animal Rat Pringle maneuver model (portal triad clamped for 30 min); liver ischemia and reperfusion. Published 2020 · PubMed PMID 32547687 ↗
research profile · published study amounts · sources (shop page) · lab-tested lots
Also listed under: Brain & nervous system, Heart & blood vessels, Kidney & urinary tract, Gut & digestive tract, Skin, Muscle & tendon, Eye
MOTS-c
- Human & animal Blood MOTS-c levels in 404 people with hepatitis B virus infection and 85 healthy subjects, plus HBV-infected mice and cells. Published 2024 · PubMed PMID 37788894 ↗
research profile · published study amounts · sources (shop page) · lab-tested lots
Also listed under: Muscle & tendon, Pancreas & adipose tissue
Selank
- Animal Rats under chronic foot-shock stress; liver morphology (hepatocytes). Published 2019 · PubMed PMID 31243679 ↗
research profile · published study amounts · sources (shop page) · lab-tested lots
Also listed under: Brain & nervous system, Gut & digestive tract, Immune system & thymus
TB-500 (thymosin beta-4)
- Animal Mice given chronic ethanol plus LPS; liver injury markers and liver pathology. Published 2018 · PubMed PMID 30116499 ↗
research profile · published study amounts · sources (shop page) · lab-tested lots
Also listed under: Brain & nervous system, Heart & blood vessels, Skin, Bone & cartilage, Eye, Lungs & airways
Thymosin alpha-1
- Human Open-label randomized controlled trial in 120 adults with hepatitis B-related acute-on-chronic liver failure. Published 2022 · PubMed PMID 35616850 ↗
- Human Randomized study in adults with HBeAg-positive chronic hepatitis B, compared with interferon alpha. Published 2006 · PubMed PMID 17075991 ↗
research profile · published study amounts · sources (shop page) · lab-tested lots
Also listed under: Immune system & thymus
Retatrutide
- Human Substudy of a phase 2 trial in 98 participants with steatotic liver disease and at least 10% liver fat; liver fat at 24 weeks. Published 2024 · PubMed PMID 38858523 ↗
published study amounts · lab-tested lots
Also listed under: Pancreas & adipose tissue
Semaglutide
- Human ESSENCE: phase 3 trial in 1197 adults with biopsy-defined MASH and fibrosis stage 2 or 3. Published 2025 · PubMed PMID 40305708 ↗
published study amounts · lab-tested lots
Also listed under: Heart & blood vessels, Kidney & urinary tract, Pancreas & adipose tissue
Survodutide
- Human 48-week phase 2 trial in adults with biopsy-confirmed MASH and liver fibrosis stage F1 to F3. Published 2024 · PubMed PMID 38847460 ↗
published study amounts · lab-tested lots
Also listed under: Pancreas & adipose tissue
Tirzepatide
- Human 52-week phase 2 trial in adults with biopsy-confirmed MASH and stage F2 or F3 fibrosis. Published 2024 · PubMed PMID 38856224 ↗
published study amounts · lab-tested lots
Also listed under: Heart & blood vessels, Pancreas & adipose tissue
About this page
- A compound is listed under an organ only when at least one published study or trial we could cite looked at that organ or tissue.
- Sentences describe the model and tissue; they do not report results. Follow the citation for what the authors found.
- Only abstracts and open-access full texts were used.
See also: all organ systems · all compound profiles.